“The first half of 2026 marked an important period of execution and momentum for Aclarion,” said Brent Ness, Chief Executive Officer of Aclarion. Key highlights include:141% year-over-year scan volume growth and 71% sequential scan volume growth in first half of 2026 , reflecting accelerating clinical adoption and broader integration into physician workflows. For more News from Aclarion, please visit: Latest NewsTo find a Nociscan center, view our site map here. Statements that are not historical facts, such as “anticipates,” “believes” and “expects” or similar expressions, are forward-looking statements. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.